Build with KISHO Sign In Sign Up

Kisho

ChemoCentryx, Inc. — Rare Disease Pipeline | Kisho | Kisho

ChemoCentryx, Inc.

Other

4

Orphan Designations

1

FDA Approvals

16

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
Chilton-Okur-Chung neurodevelopmental syndrome	Tavneos	Orphan Designation	-
Okur-Chung neurodevelopmental syndrome	Tavneos	Orphan Designation	-
Pan-Chung-Bellen syndrome	Tavneos	Orphan Designation	-
adult neuronal ceroid lipofuscinosis	Tavneos	Orphan Designation	-
adult pleomorphic rhabdomyosarcoma	Tavneos	Orphan Designation	-
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia	Tavneos	Orphan Designation	-
adult-onset proximal spinal muscular atrophy, autosomal dominant	Tavneos	Orphan Designation	-
anti-neutrophil cytoplasmic antibody-associated vasculitis	Tavneos	Orphan Designation	-
atypical hemolytic-uremic syndrome	avacopan	Orphan Designation	-
eosinophilic granulomatosis with polyangiitis	Tavneos	Orphan Designation	-
focal segmental glomerulosclerosis	4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)-3-pyridinyl]-3-(trifluoromethyl)benzenesulfonamide, sodium salt	Orphan Designation	-
microscopic polyangiitis	Tavneos	Orphan Designation	-
non-immunoglobulin-mediated membranoproliferative glomerulonephritis	avacopan	Orphan Designation	-
pauci-immune glomerulonephritis with ANCA	Tavneos	Orphan Designation	-
pauci-immune glomerulonephritis without ANCA	Tavneos	Orphan Designation	-
primary adult heart tumor	Tavneos	Orphan Designation	-

← Back to Companies